These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 9817477

  • 41. Differential contribution of nitric oxide to regulation of vascular tone in coronary conductance and resistance arteries: intravascular ultrasound studies.
    Sudhir K, MacGregor JS, Amidon TM, Gupta M, Yock PG, Chatterjee K.
    Am Heart J; 1994 Apr; 127(4 Pt 1):858-65. PubMed ID: 7512309
    [Abstract] [Full Text] [Related]

  • 42. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia.
    Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama K.
    Heart; 2002 Mar; 87(3):264-9. PubMed ID: 11847169
    [Abstract] [Full Text] [Related]

  • 43. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation.
    Quyyumi AA, Dakak N, Diodati JG, Gilligan DM, Panza JA, Cannon RO.
    J Am Coll Cardiol; 1997 Nov 01; 30(5):1220-7. PubMed ID: 9350919
    [Abstract] [Full Text] [Related]

  • 44. Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms.
    Egashira K, Hirooka Y, Kuga T, Mohri M, Takeshita A.
    Circulation; 1996 Jul 15; 94(2):130-4. PubMed ID: 8674170
    [Abstract] [Full Text] [Related]

  • 45. Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs.
    Chu A, Chambers DE, Lin CC, Kuehl WD, Cobb FR.
    Am J Physiol; 1990 Apr 15; 258(4 Pt 2):H1250-4. PubMed ID: 2331014
    [Abstract] [Full Text] [Related]

  • 46. In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation.
    Nishikawa Y, Stepp DW, Chilian WM.
    Am J Physiol; 1999 Sep 15; 277(3):H1252-9. PubMed ID: 10484447
    [Abstract] [Full Text] [Related]

  • 47. Acute effects of 17 beta-estradiol on the coronary microcirculation: observations in sedated, closed-chest domestic swine.
    Berman M, Gewirtz H.
    Coron Artery Dis; 1997 Jun 15; 8(6):351-61. PubMed ID: 9347215
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Endothelial dysfunction in patients with chest pain and normal coronary arteries.
    Quyyumi AA, Cannon RO, Panza JA, Diodati JG, Epstein SE.
    Circulation; 1992 Dec 15; 86(6):1864-71. PubMed ID: 1451258
    [Abstract] [Full Text] [Related]

  • 50. Effects of Inhibition of Nitric Oxide Synthase on Muscular Arteries During Exercise: Nitric Oxide Does Not Contribute to Vasodilation During Exercise or in Recovery.
    O'Gallagher K, Shabeeh H, Munir S, Roomi A, Jiang B, Guilcher A, Brett S, Chowienczyk P.
    J Am Heart Assoc; 2020 Aug 18; 9(16):e013849. PubMed ID: 32781940
    [Abstract] [Full Text] [Related]

  • 51. Effect of enalaprilat on nitric oxide activity in coronary artery disease.
    Prasad A, Husain S, Quyyumi AA.
    Am J Cardiol; 1999 Jul 01; 84(1):1-6. PubMed ID: 10404842
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Endogenous nitric oxide prevents myocardial ischemia in patients with hypertension and left ventricular hypertrophy.
    Mohri M, Ichiki T, Hirooka Y, Takeshita A.
    Am Heart J; 2002 Apr 01; 143(4):684-9. PubMed ID: 11923806
    [Abstract] [Full Text] [Related]

  • 54. Leptin causes nitric-oxide independent coronary artery vasodilation in humans.
    Matsuda K, Teragawa H, Fukuda Y, Nakagawa K, Higashi Y, Chayama K.
    Hypertens Res; 2003 Feb 01; 26(2):147-52. PubMed ID: 12627874
    [Abstract] [Full Text] [Related]

  • 55. [Role of endothelium-derived nitric oxide in sustained flow-dependent dilatation of human peripheral conduit arteries].
    Bellien J, Joannidès R, Iacob M, Eltchaninoff H, Thuillez Ch.
    Arch Mal Coeur Vaiss; 2003 Feb 01; 96(7-8):738-41. PubMed ID: 12945214
    [Abstract] [Full Text] [Related]

  • 56. Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humans.
    Prasad A, Husain S, Schenke W, Mincemoyer R, Epstein N, Quyyumi AA.
    J Am Coll Cardiol; 2000 Nov 01; 36(5):1467-73. PubMed ID: 11079644
    [Abstract] [Full Text] [Related]

  • 57. Flow-mediated dilatation in the superficial femoral artery is nitric oxide mediated in humans.
    Kooijman M, Thijssen DH, de Groot PC, Bleeker MW, van Kuppevelt HJ, Green DJ, Rongen GA, Smits P, Hopman MT.
    J Physiol; 2008 Feb 15; 586(4):1137-45. PubMed ID: 18096601
    [Abstract] [Full Text] [Related]

  • 58. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.
    Cooper CJ, Landzberg MJ, Anderson TJ, Charbonneau F, Creager MA, Ganz P, Selwyn AP.
    Circulation; 1996 Jan 15; 93(2):266-71. PubMed ID: 8548898
    [Abstract] [Full Text] [Related]

  • 59. Nitric oxide is not obligatory for radial artery flow-mediated dilation following release of 5 or 10 min distal occlusion.
    Pyke K, Green DJ, Weisbrod C, Best M, Dembo L, O'Driscoll G, Tschakovsky M.
    Am J Physiol Heart Circ Physiol; 2010 Jan 15; 298(1):H119-26. PubMed ID: 19880668
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.